On December 6, 2001, Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) announced that it had signed a definitive agreement to acquire COR Therapeutics, Inc. (Nasdaq: CORR) in a stock-for-stock exchange valued at $2.0 billion.
Millennium was advised by the following Hale and Dorr lawyers:
- on real estate matters, partner Keith Barnett;
- on employee benefits matters, partner Bill Schmidt; and
- on immigration matters, partner Carolyn Fuchs.